Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders
Alpha-synuclein (aSyn) is a pre-synaptic monomeric protein that can form aggregates in neurons in Parkinson’s disease (PD), Parkinson’s disease with dementia (PDD) and dementia with Lewy bodies (DLB), and in oligodendrocytes in multiple system atrophy (MSA). Although aSyn in astrocytes has previousl...
Main Authors: | Altay, MF, Liu, AKL, Holton, JL, Parkkinen, L, Lashuel, HA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2022
|
Similar Items
-
Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia
by: Parkkinen, L, et al.
Published: (2004) -
Assessment of α-Synuclein Pathology
by: Alafuzoff, I, et al.
Published: (2008) -
Glucocerebrosidase mutations do not cause increased Lewy body pathology in Parkinson's disease
by: Parkkinen, L, et al.
Published: (2011) -
Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium
by: Alafuzoff, I, et al.
Published: (2009) -
Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance
by: Parkkinen, L, et al.
Published: (2008)